¿Es el uso intravenoso del agonista selectivo de los receptores opioides kappa difelicefalina (CR845) un tratamiento seguro y eficaz para el prurito moderado-intenso de los pacientes en hemodiálisis?
Read
5875
Timeswas read the article
2818
Total PDF
3057
Total HTML
Article information
ISSN: 18889700Original language: Spanish
The statistics are updated each day
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 14 | 5 | 19 |
| 2025 5 | 103 | 46 | 149 |
| 2025 4 | 74 | 28 | 102 |
| 2025 3 | 97 | 49 | 146 |
| 2025 2 | 98 | 39 | 137 |
| 2025 1 | 147 | 42 | 189 |
| 2024 12 | 83 | 48 | 131 |
| 2024 11 | 82 | 63 | 145 |
| 2024 10 | 71 | 50 | 121 |
| 2024 9 | 65 | 43 | 108 |
| 2024 8 | 98 | 73 | 171 |
| 2024 7 | 66 | 40 | 106 |
| 2024 6 | 55 | 39 | 94 |
| 2024 5 | 50 | 47 | 97 |
| 2024 4 | 74 | 37 | 111 |
| 2024 3 | 64 | 51 | 115 |
| 2024 2 | 58 | 35 | 93 |
| 2024 1 | 96 | 32 | 128 |
| 2023 12 | 46 | 24 | 70 |
| 2023 11 | 39 | 21 | 60 |
| 2023 10 | 49 | 32 | 81 |
| 2023 9 | 72 | 42 | 114 |
| 2023 8 | 39 | 31 | 70 |
| 2023 7 | 62 | 47 | 109 |
| 2023 6 | 58 | 29 | 87 |
| 2023 5 | 64 | 51 | 115 |
| 2023 4 | 61 | 36 | 97 |
| 2023 3 | 34 | 36 | 70 |
| 2023 2 | 65 | 36 | 101 |
| 2023 1 | 42 | 35 | 77 |
| 2022 12 | 50 | 34 | 84 |
| 2022 11 | 59 | 38 | 97 |
| 2022 10 | 53 | 41 | 94 |
| 2022 9 | 51 | 50 | 101 |
| 2022 8 | 39 | 53 | 92 |
| 2022 7 | 35 | 57 | 92 |
| 2022 6 | 42 | 52 | 94 |
| 2022 5 | 25 | 43 | 68 |
| 2022 4 | 39 | 66 | 105 |
| 2022 3 | 38 | 86 | 124 |
| 2022 2 | 40 | 52 | 92 |
| 2022 1 | 39 | 66 | 105 |
| 2021 12 | 34 | 84 | 118 |
| 2021 11 | 44 | 64 | 108 |
| 2021 10 | 54 | 98 | 152 |
| 2021 9 | 58 | 68 | 126 |
| 2021 8 | 62 | 60 | 122 |
| 2021 7 | 25 | 49 | 74 |
| 2021 6 | 27 | 58 | 85 |
| 2021 5 | 19 | 78 | 97 |
| 2021 4 | 51 | 156 | 207 |
| 2021 3 | 42 | 67 | 109 |
| 2021 2 | 38 | 65 | 103 |
| 2021 1 | 25 | 44 | 69 |
| 2020 12 | 30 | 52 | 82 |
| 2020 11 | 10 | 41 | 51 |
| 2020 10 | 2 | 9 | 11 |
Show all
